US EditionINVO Bioscience Announces Compliance with Nasdaq Listing Rule
Summary by Clayton County Register
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
INVO Bioscience Announces Compliance with Nasdaq Listing Rule
SARASOTA, Fla., Nov. 28, 2023 – INVO Bioscience, a leading healthcare services company specializing in fertility treatment, has received confirmation from The Nasdaq Capital Market that it has regained compliance with the minimum stockholders’ equity requirement for continued listing on Nasdaq. This news comes after the company was previously notified of non-compliance in November 2022. To meet the stockholders’ equity rule, INVO Bioscience ente…
·Elkader, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
